- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04820647
KF STRIDE to Improve Job Interview Skills
March 19, 2024 updated by: Helen Genova, Kessler Foundation
A Strength-Based Intervention to Improve Job Interview Skills in Young Adults
The goals of the current study are to evaluate the preliminary effectiveness and feasibility of Kessler Foundation-Strength Identification and Expression (KF-STRIDE) in an 8-week randomized controlled trial comparing the intervention to services as usual (SAU).
Study Overview
Detailed Description
This study will evaluate the acceptability and effectiveness of a strength-based intervention (Kessler Foundation Strength Identification and Expression; KF-STRIDE) that can enhance job interview skills and employment.
Despite possessing employable talents, the core social deficits of transition age youth with autism spectrum disorder (TAY-ASD) make it difficult for this group to articulate their individual strengths.
This inability to identify and express one's strengths to a potential employer can negatively affect interview performance and lead to difficulty with job obtainment.
Thus, the current proposal will examine the effectiveness (Aim 1), acceptability, usability, and feasibility (Aim 2) of a novel strength-based intervention, KF-STRIDE, which is designed to enhance the ability of TAY-ASD to identify personal strengths and effectively discuss them.
The goals of the current study are to evaluate the preliminary effectiveness and feasibility of KF-STRIDE in an 8-week randomized controlled trial comparing the intervention to services as usual (SAU).
The study will be performed at two private therapeutic schools.
Compared to a SAU group, we hypothesize that the KF-STRIDE group will: a) improve the ability to identify strengths (Hypothesis 1), b) improve the ability to express strengths (Hypothesis 2), c) improve other job interview skills (Hypothesis 3) and finally c) improve ability to obtain employment 6-months following the intervention (Hypothesis 4).
In this way, the current study is in line with the NIMH's experimental therapeutics model, as we will examine whether the intervention improves employment, as well as identify potential mechanistic targets that could affect outcome.
In Aim 2, we will also monitor fidelity, acceptability, usability, and feasibility of the strength-based intervention.
The long-term goal of the current research is to collect pilot data that will lead to fully-powered effectiveness and implementation evaluations of KF-STRIDE in other community settings.
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Jersey
-
East Hanover, New Jersey, United States, 07936
- Kessler Foundation
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 26 years (Child, Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- adolescents with Autism Spectrum Disorder
- Live in the United States of America
- Ages of 14-26
- Speak English fluently and at a 4th grade reading level
Exclusion Criteria:
- History of stroke, Traumatic Brain Injury, or neurological injury or disease in the past (like brain tumor or epilepsy).
- History of significant psychiatric illness
- Uncontrolled seizures or other unstable medical complications.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Kessler Foundation STRength IDentification and Expression (KF-STRIDE)
|
KF Stride works to improve identification (awareness) of personal character strengths and 2) express them in a socially appropriate way during a job interview
|
No Intervention: Services as Usual
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mock Job Interview
Time Frame: Week 8
|
Blinded reviewers using a standardized scoring measure will rate the video recorded mock job interviews.
|
Week 8
|
employment status (yes=1, no=0)
Time Frame: 6 months post intervention
|
We will examine whether the person became employed or other changes to their employment status.
|
6 months post intervention
|
time-to-reach-employment (assessed as weeks since intervention completion).
Time Frame: 6 months post intervention
|
We will examine how long it took for the person to obtain employment.
|
6 months post intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 29, 2021
Primary Completion (Actual)
January 12, 2024
Study Completion (Actual)
January 12, 2024
Study Registration Dates
First Submitted
March 25, 2021
First Submitted That Met QC Criteria
March 26, 2021
First Posted (Actual)
March 29, 2021
Study Record Updates
Last Update Posted (Actual)
March 20, 2024
Last Update Submitted That Met QC Criteria
March 19, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- E-1139-21
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Stanford UniversityCalifornia Department of Developmental ServicesRecruitingAutism Spectrum Disorder | Autistic Disorder | Autism | Autism Spectrum Disorders | Autistic Disorders Spectrum | Autistic Spectrum Disorder | Autistic Spectrum DisordersUnited States
-
Hoffmann-La RocheActive, not recruitingAutism Spectrum Disorder (ASD)United States, Canada, Italy, Spain
-
Axial Therapeutics, Inc.Active, not recruitingAutism Spectrum Disorder (ASD)United States, Australia, New Zealand
-
Technion, Israel Institute of TechnologyCompleted
-
Stanford UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedAutism | Autism Spectrum Disorder (ASD)United States
-
Corporacion Parc TauliUnknown
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyTerminatedAutism Spectrum Disorder (ASD)Spain, United States, Hungary, Poland, Australia, United Kingdom, Brazil, Czechia, France, Italy, Portugal, Slovakia
-
Florida Gulf Coast UniversityCompletedAutism Spectrum Disorder High-FunctioningUnited States
-
Hospital Universitario Dr. Jose E. GonzalezUnknownAutism | Autism SpectrumMexico
-
National Taiwan University HospitalCompletedAutism Spectrum Disorder High-FunctioningTaiwan
Clinical Trials on KF-STRIDE
-
Kessler FoundationCompletedAutism Spectrum Disorder | Autism | ASDUnited States
-
Kessler FoundationNot yet recruitingA Strength-Based Intervention to Improve Job Interview Skills in Young Adults in a Community SettingAutism Spectrum Disorder
-
Kessler FoundationRecruiting
-
Joslin Diabetes CenterBrown University; Theoria MedicalEnrolling by invitationDiabetes | Dementia | Hypoglycemia; DrugUnited States
-
Keythera Pharmaceuticals (Australia) Pty LtdRecruitingGastric Cancer | Colorectal Cancer | Lung Cancer | Bladder Cancer | Advanced Solid Tumor | Squamous Cell Carcinoma of the EsophagusAustralia
-
University of New MexicoNational Cancer Institute (NCI)CompletedValidate STRIDE Exercise Intervention in Sedentary Individuals | Increase Positive Attitudes, Perceived Normative Support, Self-efficacy, and Intentions | Increase Self-reported Physical ActivityUnited States
-
The Miriam HospitalUniversity of Pittsburgh; Brown University; Stanford UniversityCompleted
-
VA Office of Research and DevelopmentCompleted
-
Kessler FoundationRecruitingTraumatic Brain InjuryUnited States
-
VA Office of Research and DevelopmentCompletedDiabetes MellitusUnited States